Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray Kausik Kumar; Ray; Kausik Kumar; Colhoun Helen M.; Colhoun; Szarek Michael; Helen M.; Baccara-Dinet Marie; Bhatt Deepak L.; Szarek; Bittner Vera A.; Michael; Budaj Andrzej J.; Baccara-Dinet; Marie; Diaz Rafael; Goodman Shaun G.; Bhatt; Deepak L.; Bittner; Vera A.; Budaj; Andrzej J.; Diaz; Rafael; Goodman; Shaun G.; Andrejs Ērglis

doi:10.1016/S2213-8587(19)30158-5

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray Kausik Kumar
, Ray
, Kausik Kumar
, Colhoun Helen M.
, Colhoun
, Szarek Michael
, Helen M.
, Baccara-Dinet Marie
, Bhatt Deepak L.
, Szarek
, Bittner Vera A.
, Michael
, Budaj Andrzej J.
, Baccara-Dinet
, Marie
, Diaz Rafael
, Goodman Shaun G.
, Bhatt
, Deepak L.
, Bittner

Vera A., Budaj, Andrzej J., Diaz, Rafael, Goodman, Shaun G., Andrejs Ērglis

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

291 Atsauces (Scopus)

Oriģinālvaloda	Angļu
Lapas (no-līdz)	618-628
Žurnāls	The Lancet Diabetes and Endocrinology
Sējums	7
Izdevuma numurs	8
DOIs	https://doi.org/10.1016/S2213-8587(19)30158-5
Publikācijas statuss	Publicēts - 2019

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

3. IAM — Laba Veselība un Labbūtība

OECD Zinātnes nozare

3. Medicīnas un veselības zinātnes

Piekļuve Dokumentiem

10.1016/S2213-8587(19)30158-5

Citi faili un saites

https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2213858719301585

Citēt šo

Kausik Kumar, R., Ray, Kausik Kumar, Helen M., C., Colhoun, Michael, S., Helen M., Marie, B.-D., Deepak L., B., Szarek, Vera A., B., Michael, Andrzej J., B., Baccara-Dinet, Marie, Rafael, D., Shaun G., G., Bhatt, Deepak L., ... Ērglis, A. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. The Lancet Diabetes and Endocrinology, 7(8), 618-628. https://doi.org/10.1016/S2213-8587(19)30158-5

@article{690f81caabb7421eab14fc11506ff385,

title = "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial",

author = "\{Kausik Kumar\}, Ray and Ray and \{Kausik Kumar\} and \{Helen M.\}, Colhoun and Colhoun and Szarek Michael and \{Helen M.\} and Baccara-Dinet Marie and \{Deepak L.\}, Bhatt and Szarek and \{Vera A.\}, Bittner and Michael and \{Andrzej J.\}, Budaj and Baccara-Dinet and Marie and Diaz Rafael and \{Shaun G.\}, Goodman and Bhatt and \{Deepak L.\} and Bittner and \{Vera A.\} and Budaj and \{Andrzej J.\} and Diaz and Rafael and Goodman and \{Shaun G.\} and Andrejs Ērglis",

year = "2019",

doi = "10.1016/S2213-8587(19)30158-5",

language = "English",

volume = "7",

pages = "618--628",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier Ltd",

number = "8",

}

Kausik Kumar, R, Ray, Kausik Kumar, Helen M., C, Colhoun, Michael, S, Helen M., Marie, B-D, Deepak L., B, Szarek, Vera A., B, Michael, Andrzej J., B, Baccara-Dinet, Marie, Rafael, D, Shaun G., G, Bhatt, Deepak L., Bittner, Vera A., Budaj, Andrzej J., Diaz, Rafael, Goodman, Shaun G., & Ērglis, A 2019, 'Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial', The Lancet Diabetes and Endocrinology, sēj. 7, Nr. 8, lpp. 618-628. https://doi.org/10.1016/S2213-8587(19)30158-5

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. / Kausik Kumar, Ray; Ray; Kausik Kumar u.c.
(gadā): The Lancet Diabetes and Endocrinology, Sēj. 7, Nr. 8, 2019, lpp. 618-628.

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

TY - JOUR

T1 - Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

AU - Kausik Kumar, Ray

AU - Ray, null

AU - Kausik Kumar, null

AU - Helen M., Colhoun

AU - Colhoun, null

AU - Michael, Szarek

AU - Helen M., null

AU - Marie, Baccara-Dinet

AU - Deepak L., Bhatt

AU - Szarek, null

AU - Vera A., Bittner

AU - Michael, null

AU - Andrzej J., Budaj

AU - Baccara-Dinet, null

AU - Marie, null

AU - Rafael, Diaz

AU - Shaun G., Goodman

AU - Bhatt, null

AU - Deepak L., null

AU - Bittner, null

AU - Vera A., null

AU - Budaj, null

AU - Andrzej J., null

AU - Diaz, null

AU - Rafael, null

AU - Goodman, null

AU - Shaun G., null

AU - Ērglis, Andrejs

PY - 2019

Y1 - 2019

UR - https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2213858719301585

U2 - 10.1016/S2213-8587(19)30158-5

DO - 10.1016/S2213-8587(19)30158-5

M3 - Article

SN - 2213-8587

VL - 7

SP - 618

EP - 628

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 8

ER -

Kausik Kumar R, Ray, Kausik Kumar, Helen M. C, Colhoun, Michael S u.c. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. The Lancet Diabetes and Endocrinology. 2019;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5